Last reviewed · How we verify
NCT06634602
The Effect of Sports and Arts on Job Engagement Among Physicians
trial in Job Engagement in 130 participants. Completed in 15 May 2024.
30 April 2024
Quick facts
| Lead sponsor | Buğu Usanma Koban |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 130 |
| Start date | 5 January 2024 |
| Primary completion | 30 April 2024 |
| Estimated completion | 15 May 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Job Engagement — all drugs for Job Engagement →
- Leisure Activities — all drugs for Leisure Activities →
Sponsor
Buğu Usanma Koban
Who can join
Eligibility, any sex, with Job Engagement or Leisure Activities. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study was to learn about the relationship between the sociodemographic characteristics or leisure time activities of physicians and their job engagement. The main question it aims to answer was: Do sports or artistic activities increase job engagement among physicians? A survey was administered to physicians, to collect sociodemographic and professional characteristics (including sports and artistic activities), followed by a face-to-face application of the Utrecht Work Engagement Scale (UWES-17).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06634602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06634602 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Buğu Usanma Koban
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06634602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing